Talk on AI and Precision Medicine from Founder and Director of Scripps Research Translational Institute
Deep learning, a subtype of artificial intelligence (AI), has considerable transformative potential to promote accuracy, streamline workflow, synthesize data for both clinicians and patients, promote patient autonomy, and greatly enhance the patient-clinician relationship. To date, however, prospective validation studies are quite limited.
Dr. Eric Topol, M.D., will discuss how we need to confront such vital issues of how AI can unintentionally worsen inequities and discrimination. The goal, which may be considered counter-intuitive, is to use this technology to make medicine more human.
Eric Topol, M.D., founder and director of the Scripps Research Translational Institute, is widely known for his development of genomic and digital tools coupled with AI analytics geared to individualize medicine.
Upcoming Events
- Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncologyJuly 30, 2024CCDI Federated Data: Enhancing Data DiscoverabilityAugust 13, 2024Leveraging High-Performance Computing Resources and Using QIIME 2 to Advance Your Microbiome ProjectsAugust 27, 2024 - August 29, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024